You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 10, October 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bloom's Syndrome

Clinical Features and Immunologic Abnormalities of Four Patients

Catherine W. Van Kerckhove, MD; Jan L. Ceuppens, MD, PhD; Magda Vanderschueren-Lodeweyckx, MD, PhD; Ephrem Eggermont, MD, PhD; Simmone Vertessen; Erik A. M. Stevens, MD

Am J Dis Child. 1988;142(10):1089-1093.


Abstract

• Immune function was studied in four patients (two girls and two boys, aged 30 months to 24 years) with documented Bloom's syndrome. Three patients had a decreased serum concentration of at least one subclass of immunoglobulins. All had normal or elevated proportions of circulating B cells but two of them had a decreased proportion of CD4-positive helper-inducer T cells. We consistently found a severely impaired in vitro proliferative lymphocyte response to the plant lectin pokeweed mitogen (PWM). This could not be overcome by using suboptimal or supraoptimal doses of PWM, or by adding recombinant interleukin 2. In vitro PWM-induced lgM production was absent or low in two of the three patients studied and this low production could not be increased by addition of hydrocortisone. T lymphocytes responded normally to the plant lectins phytohemagglutinin and concanavalin A. T cells preactivated with phytohemagglutinin also normally proliferated in response to interleukin 2. It has previously been shown that lymphocyte activation with PWM involves both B and T cells and proceeds via an alternative pathway. The data thus indicate that patients with Bloom's syndrome have a specific defect in this PWM-induced alternative pathway of lymphocyte activation.

(AJDC 1988;142:1089-1093)



Author Affiliations

From the Department of Pediatrics (Drs Van Kerckhove, Eggermont, and Vanderschueren-Lodeweyckx) and the Division of Clinical Immunology (Drs Ceuppens and Stevens and Ms Vertessen), Faculty of Medicine, University of Leuven, Belgium.; Dr Van Kerckhove is a research associate of the Belgian Nationaal Fonds voor Wetenschappelijk Onderzoek.


Footnotes

Accepted for publication May 26, 1988.

Reprint requests to Laboratory of Clinical Immunology, University Hospital, Capucijnenvoer 33, 3000 Leuven, Belgium (Dr Ceuppens).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genomic Instability Resulting from Blm Deficiency Compromises Development, Maintenance, and Function of the B Cell Lineage
Babbe et al.
J. Immunol. 2009;182:347-360.
ABSTRACT | FULL TEXT  

The Bloom's Syndrome Helicase Is Critical for Development and Function of the {alpha}{beta} T-Cell Lineage
Babbe et al.
Mol. Cell. Biol. 2007;27:1947-1959.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.